These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 13038721)
1. The use of polyvinylpyrrolidone as a plasma volume expander in preventing or combating shock. SINGLETON AO Tex Rep Biol Med; 1953; 11(1):138-43. PubMed ID: 13038721 [No Abstract] [Full Text] [Related]
2. Plasma expanders in surgical shock. WEIL PG; BALDRY RE Can Serv Med J; 1954 Dec; 10(5):293-8. PubMed ID: 13209506 [No Abstract] [Full Text] [Related]
3. Plasma expanders in surgical shock. WEIL PG; BALDRY RE Can Hosp; 1955 May; 32(5):47; passim. PubMed ID: 14379067 [No Abstract] [Full Text] [Related]
4. Evaluation of plasma substitutes in wound shock: polyvinylpyrrolidone. HAYNES BW; CRAWFORD ES; MAHAFFEY JH; DE BAKEY ME Surg Forum; 1953; (38th Congress):433-40. PubMed ID: 13122477 [No Abstract] [Full Text] [Related]
6. The use of polyvinylpyrrolidone in the management of shock-like states; report of a case. O'CONNEL CL; GREENLEE DP; HERRON FT Pa Med J; 1953 Sep; 56(9):813-4. PubMed ID: 13088238 [No Abstract] [Full Text] [Related]
11. [Shock therapy with Haemaccel, a new plasma volume expander]. FROESCHLIN W Dtsch Med Wochenschr; 1962 Apr; 87():811-4 passim. PubMed ID: 13895455 [No Abstract] [Full Text] [Related]
12. [Blood and plasma substitutes in combating various forms of shock]. FOA C Resen Clin Cient; 1947 Sep; 16(9):323-8. PubMed ID: 18859014 [No Abstract] [Full Text] [Related]
13. [Danger to patients of therapy with colloidal plasma substitutes]. BUSCH H Ther Ggw; 1955 Sep; 94(9):324-7. PubMed ID: 13291265 [No Abstract] [Full Text] [Related]
14. A review on the status of the so-called blood plasma substitutes. ATIENZA RY; ZALAMEA RU J Philipp Med Assoc; 1954 Jul; 30(7):346-57. PubMed ID: 13202054 [No Abstract] [Full Text] [Related]
16. A comparison of plasma substitutes (dextran, polyvinylpyrrolidone and oxypolygelatin) with saline therapy in treatment of experimental tourniquet and burn shock in mice. MILLICAN RC; STOHLMAN EF; MOWRY RW Am J Physiol; 1952 Jul; 170(1):173-8. PubMed ID: 12985881 [No Abstract] [Full Text] [Related]
17. [Incorporation of physiologically-active substances into a colloidal blood plasma substitute. I. Incorporation of mescaline peptide into polyvinylpyrrolidone]. JATZKEWITZ H Hoppe Seylers Z Physiol Chem; 1954; 297(3-6):149-56. PubMed ID: 13221275 [No Abstract] [Full Text] [Related]
18. [Therapy of wound shock with plasma and plasma substitutes]. HEIM W; OSTEN W Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1954; 278(5):453-76. PubMed ID: 13234432 [No Abstract] [Full Text] [Related]
20. The clinical status of dextran, PVP and gelatin products. PULASKI EJ Int Rec Med Gen Pract Clin; 1952 Aug; 165(8):172-9. PubMed ID: 13010904 [No Abstract] [Full Text] [Related] [Next] [New Search]